SINGH BROTHERS FINED RS 2,600 CR FOR HIDING FACTS FROM DAIICHI

New Delhi, Medicare News, May 15, 2016

Billionaire businessman Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh have been fined nearly Rs 2,600 crore, media reports say.
The erstwhile promoters of drug maker Ranbaxy were penalised for concealing and misrepresenting facts from Japanese pharmaceutical company, Daiichi Sankyo about its 2008 deal involving the sale of controlling stake in Ranbaxy.

The fine was decided by Singapore International Arbitration Centre (SIAC), which heard an arbitration case filed by Daiichi Sankyo in 2013. The Singh brothers, former Ranbaxy owners, had sold their stake to Daiichi Sankyo for $2.4 billion in 2008.

Japanese drugmaker Daiichi Sankyo later sold Ranbaxy to Mumbai-based Sun Pharma. The Singh brothers now run hospitals under the Fortis brand. They also own financial services firm Religare Enterprises.

Related Posts

Centre Pushes Haryana to Fast-Track AIIMS Rewari

New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug